BIOMARKER:

LYN mutation

Entrez ID:

Related biomarkers:

‹

›

LYN mutation LYN mutation	Non Small Cell Lung Cancer NSCLC	LYN mutation LYN mutation	Non Small Cell Lung Cancer NSCLC	nivolumab + ipilimumab Sensitive: C3 – Early Trials	nivolumab + ipilimumab Sensitive: C3 – Early Trials
LYN mutation LYN mutation	Melanoma Melanoma	LYN mutation LYN mutation	Melanoma Melanoma	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials

Associations